查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439903

數位吸入器 - 全球市場考量、競爭格局、市場預測 (2030)

Digital Dose Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計 2024 年至 2030 年預測期內，全球數位吸入器市場規模將以 11.27% 的複合年增長率成長。 由於氣喘、慢性阻塞性肺病（COPD）、囊性纖維化和氣喘-COPD重疊症候群等呼吸系統疾病盛行率上升等因素，該市場呈現顯著的市場成長。 此外，領先製藥公司快速採用數位技術、空氣污染加劇、吸菸者數量增加以及接觸灰塵、煙霧和空氣顆粒的增加將推動數位吸入器市場的發展。 此外，預計近期產品發佈和監管批准等技術進步將在預測期內（2024-2030 年）推動整個數位吸入器市場的發展。 因此，預計在 2024 年至 2030 年的預測期內，市場將以顯著的複合年增長率成長。

數位吸入器市場動態

推動數位吸入器市場的關鍵特徵之一是各種呼吸系統疾病的全球盛行率不斷上升。

例如，根據世界衛生組織 (WHO) (2022) 的數據，氣喘在 2019 年影響了近 2.62 億人，同年導致全球 4.55 億人死亡。

根據全球疾病負擔研究（2019）的數據，全球慢性阻塞性肺病患者人數據報告為2.123億，2019年有330萬人死亡。我是。 除了氣喘和慢性阻塞性肺病之外，囊性纖維化的病例也在增加。 根據 March of Dimes Organization（2019 年）的數據，2019 年全球約有 70,000 至 100,000 人受到囊性纖維化的影響，男性和女性的患病率相同。

此外，預計空氣污染的加劇也將推動未來幾年對數位吸入器的需求。 例如，根據經濟合作暨發展組織（2022 年）的數據，到 2050 年，全球溫室氣體 (GHG) 排放量預計將增加約 50%，這主要是由於與能源相關的二氧化碳排放量。70%。 此外，到 2050 年，大氣中溫室氣體濃度可能達到 685 ppm CO2 當量，導致本世紀末全球平均氣溫比工業化前水平上升 3 到 6 攝氏度。我是。

除上述因素外，技術的發展不斷加快，推動了數位吸入器市場的成長。 例如，2022 年 2 月，藥物輸送系統、服務和活性材料科學解決方案的全球領導者 Aptar Pharma 宣佈推出一款創新數位設備，可將標準計量吸入器 (pMDI) 轉變為智慧互聯醫療設備。我們宣佈推出HeroTracker®Sense，一種呼吸健康解決方案。

因此，上述因素將在 2024-2030 年預測期內推動整個數位吸入器市場的發展。

然而，設備的高成本以及對數位資料準確性的擔憂可能會對數位吸入器市場的成長構成挑戰。

由於封鎖、邊境關閉等原因，COVID-19 大流行減緩了數位吸入器市場最初幾個月的成長，導致數位吸入器市場的製造、供應、進出口和其他相關活動中斷。它產生了輕微的負面影響。 此外，由於擔心 SARS-CoV-2（COVID-19 的病原體）的傳播以及大流行的不確定性，世界上許多國家已停止進行肺功能測試（PFT）（除非緊急情況）。房間被迫關閉。 然而，患有中度至重度氣喘或氣喘不受控制的人更有可能因 COVID-19 住院。 由於世界各地人們對肺部健康的認識和擔憂，Covid-19大流行也導致了下半年數位吸入器的成長，這進一步導致了用於肺功能的數位或智慧吸入器等數位吸入器的成長測試.加速吸入器的使用並推動數位吸入器市場的成長。 此外，數位吸入器電子商務的推出增加了市場需求。 因此，除了上述因素外，高疫苗接種率、政府放鬆封鎖以及對數位吸入器的需求將在2022-2028年預測期內推動整個數位吸入器市場的發展。

本報告研究和分析了全球數位吸入器市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第章數位吸入器市場報告簡介

第 2 章數位吸入器市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章數位吸入器市場主要因素分析

  • 數位吸入器市場驅動因素
    • 慢性呼吸道疾病的盛行率不斷上升
    • 患有呼吸道疾病的老年人口迅速增加
    • 對技術支援的呼吸設備功能的需求不斷增加
  • 數位吸入器市場的限制與挑戰
    • 設備成本高
    • 對數字資料準確性的擔憂
  • 數位吸入器市場機遇
    • 改善發展中國家的醫療基礎設施

第5章波特數位吸入器市場五力分析

第6章 COVID-19 對數位吸入器市場的影響分析

第7章數位吸入器市場佈局

  • 依產品類型
    • 乾粉吸入器
    • 定量吸入器
  • 依用途
    • 慢性阻塞性肺病
    • 氣喘
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章數位吸入器市場：全球公司佔有率分析 - 3 至 5 家主要公司

第 9 章數位吸入器市場公司與產品概況

  • Glenmark Pharmaceuticals
  • Novartis AG
  • ResMed
  • Koninklijke Philips N.V.
  • Teva Pharmaceutical Industries Ltd.
  • H&T Presspart Manufacturing Ltd.
  • AptarGroup, Inc.
  • Amiko Digital Health Limited.
  • Trudell Medical UK Limited
  • BreatheSuite Inc.
  • Opko Health, Inc.
  • Cipla Inc.
  • Sensirion AG
  • 3M
  • Adherium

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0580

DIGITAL DOSE INHALERS MARKET BY PRODUCT TYPE (DRY POWDER INHALERS AND METERED DOSE INHALERS), BY APPLICATION (CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO ADVANCE AT A RESPECTABLE CAGR FORECAST till 2030 OWING TO THE ACCELERATING PREVALENCE OF RESPIRATORY DISORDERS SUCH AS ASTHMA, COPD, AND OTHERS, THE RISING AIR POLLUTION, AND THE GROWING NUMBER OF PRODUCT DEVELOPMENT ACTIVITIES SUCH AS PRODUCT LAUNCHES AND REGULATORY APPROVALS ACROSS THE GLOBE

The global digital dose inhalers market will grow at a CAGR of 11.27% during the forecast period from 2024 to 2030. The digital dose inhalers market is witnessing significant market growth due to the factors such as the rising prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others. Furthermore, the surging adoption of digital technology by key pharmaceutical players, the rising air pollution, increase in the population of smokers, and increasing exposure to dust, fumes, and airborne particles will spur the market of digital dose inhalers. Additionally, the growing technological advancements such as recent product launches and regulatory approvals is expected to drive the overall market for digital dose inhalers during the forecast period (2024-2030). Therefore, the market for digital dose inhalers is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

DIGITAL DOSE INHALERS MARKET DYNAMICS:

One of the key aspect for driving the digital dose inhalers market is the rising prevalence of various respiratory disorders globally.

For instance, as per data by the World Health Organization (WHO) 2022, asthma affected approximately nearly 262 million people in 2019, causing 455,000 deaths in the same year, globally.

Also, according to data by the Global Burden of Disease Study (2019), there were 212.3 million prevalent cases of COPD reported globally, accounting for 3.3 million deaths in the year 2019. In addition to asthma and COPD, the numbers for cystic fibrosis are constantly on the rise. As per data by the March of Dimes Organization (2019), about 70,000 to 100,000 people had cystic fibrosis in the year 2019 globally, affecting males and females at the same rate.

Moreover, the rising air pollution is also expected to drive the demand for digital dose inhalers in the upcoming years. For instance, as per the Organization for Economic Co-operation and Development 2022, by 2050 the emission of global greenhouse gases (GHGs) could be anticipated to increase by about 50%, majorly owing to 70% growth in energy-related CO2 emissions. It also stated that the atmospheric concentration of GHGs could reach 685 parts per million (ppm) CO2- equivalents by 2050, resulting in the global average temperatures to be 3 to 6 degree Celsius above the pre-industrial levels by the end of the century.

Along with the factors mentioned above, the number of technological developments are constantly increasing, bolstering the growth of the digital dose inhalers market. For instance, in February 2022, Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced the launch of HeroTracker® Sense, a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device.

Therefore, the factors stated above collectively will drive the overall digital dose inhalers market during the forecast period from 2024-2030.

However, high cost of the devices, concerns regarding the accuracy of digital data, and others may prove to be challenging factors for digital dose inhalers market growth.

The COVID- 19 pandemic had a slightly negative impact on the market growth of digital dose inhalers during the initial few months owing to the lockdown impositions, border closures, and others leading to disruption in the manufacturing, supply, import, export, and other related activities of the digital dose inhalers market. Also, owing to the fear of spread of SARS-CoV-2 virus which is the causative agent for COVID-19 and uncertainties revolving around the pandemic, many countries across the world were forced to close down pulmonary function tests (PFT) laboratories except in case of emergencies. However, people suffering from moderate-to-severe or uncontrolled asthma were more likely to get hospitalized from COVID-19. The COVID -19 pandemic also led to rise in digital dose inhalers in the later half owing to the awareness and concerns regarding lung health among the people across the world which is further accelerated the utilization of respiratory inhalers such as digital or smart inhalers for the testing of lung function, driving the market growth for digital dose inhalers. Moreover, with the commencement of e-commerce availability of digital dose inhalers, increased its demand in the market. Thus, along with the above-mentioned factors, high vaccination rates and relaxations in the government-imposed lockdown, the demand for digital dose inhalers is subjected to increase driving the overall market for digital dose inhalers during the forecast period of 2022 - 2028.

DIGITAL DOSE INHALERS MARKET SEGMENT ANALYSIS:

Digital Dose Inhalers Market by Product Type (Dry Powder Inhalers and Metered Dose Inhalers), Application (Chronic Obstructive Pulmonary Disease, Asthma, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the digital dose inhalers market, the dry powder inhalers segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the increasing prevalence of respiratory diseases, increasing technological advancements pertaining to the device, and surging launches by the key players in the market.

For instance, dry powder inhalers (DPI's) in general are easier to use than the metered dose inhalers (MDI) and cause fewer irritant effects.

Moreover, concerns related to the incidences of drug irritation caused by the presence of propellant components, such as chlorofluorocarbons (CFCs) in metered dose inhalers, have favored the adoption of the dry powder inhalers, with fewer irritant effects while delivering comparable therapeutic efficacy as metered dose inhalers. Thus, the dry powder inhalers are also known as propellant free inhalers.

Further, the DPI deposit the medicine in the lungs at a much higher rate than MDIs. This makes them more efficient and effective as they can provide a higher quantity of medicine with a single dose.

Additionally, the increasing product launches are also expected to contribute to the growth of the studied segment during the forecast period. For instance, in December 2020, Berry Global launched the RS01 single-dose dry powder inhaler with built-in sensors and digital capabilities. The RS01 tracks inhaler use and connects to a companion app that provides personalized guidance to improve adherence and inhaler technique.

Therefore, owing to the advantages associated with dry powder inhaler and increasing product launches, the category is expected to witness a considerable growth eventually contributing to the overall growth of the global digital dose inhalers market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL DIGITAL DOSE INHALERS MARKET:

Among all the regions, North America is expected to dominate the global digital dose inhalers market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the escalating prevalence of various respiratory disorders, increasing burden of geriatric population prone to respiratory disorder, and the presence of key market players in the region are another factors which acts as a supportive factor for the North America's digital dose inhalers market growth.

As per the data published by World Health Organization (WHO) 2022, approximately 25 million people in the United States had asthma in the year 2020 including 4.2 million children, which equals about 1 in every 13 people.

Moreover, according to the National Center for Health Statistics 2019-2020, stated that the percentage of COPD, emphysema, or chronic bronchitis for adults aged 18 and over, in the United States, increased from 4.6% in 2019 to 5.0% in 2020.

In other countries of North America such as Canada, the numbers for respiratory ailments are substantially increasing. According to statistics by the Lung Association 2020-2022, it was concluded that about 2.6 million Canadians were living with asthma in the year 2020 - 2022.

Thus, from the above sources and statistics it can be concluded that the respiratory disorders are increasing in the North America, ultimately increasing the demand of digital dose inhalers in the market.

Additionally, as per the New Mexico Department of Health Epidemiology and Response Division, 2019, in the year 2023, approximately 16.0% of adults were current smokers and nearly 32.7% of high school students were current smokers. The increasing consumption of smoking will increase the risk of developing respiratory disorders or lung cancer, ultimately increasing the demand of digital dose inhalers in order to treat and manage the respiratory disorders.

Furthermore, the increasing product launches, regulatory approvals, acquisitions, partnerships, and other activities by key players in the region will drive the market of digital dose inhalers in the upcoming years. For instance, in July 2020, Teva Pharmaceuticals, one of the prominent player in healthcare industries, announced the launch of its ProAir Digihaler in the United States. It is used in people >=4 years old to treat or prevent bronchospasm in people who have reversible obstructive airway disease or to prevent exercise-induced bronchospasm.

Henceforth, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the digital dose inhalers market.

DIGITAL DOSE INHALERS MARKET KEY PLAYERS:

Some of the key market players operating in the digital dose inhalers market includes Glenmark Pharmaceuticals, Novartis AG, ResMed, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., H&T Presspart Manufacturing Ltd., AptarGroup, Inc., Amiko Digital Health Limited., Trudell Medical UK Limited, BreatheSuite Inc., Opko Health, Inc., Cipla Inc., Sensirion AG, 3M, adherium, and others.

RECENT DEVELOPMENTAL ACTIVITIES IN DIGITAL DOSE INHALERS MARKET:

In February 2022 Astrazeneca and Honeywell partnered to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less global warming potential than propellants currently used in respiratory medicines.

In February 2019, Propeller Health, delivering one of the digital respiratory health platform, signed a partnership with Orion Corporation in order to bring the Propeller's products among European patients.

KEY TAKEAWAYS FROM THE DIGITAL DOSE INHALERS MARKET REPORT STUDY

  • Market size analysis for current digital dose inhalers market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the digital dose inhalers market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global digital dose inhalers market.
  • Various opportunities available for the other competitor in the digital dose inhalers market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current digital dose inhalers market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for digital dose inhalers market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS DIGITAL DOSE INHALERS MARKET REPORT STUDY

  • Digital dose inhalers products providers
  • Research organizations and consulting companies
  • Digital dose inhalers -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in digital dose inhalers
  • Various end users who want to know more about the digital dose inhalers market and latest technological developments in the digital dose inhalers market.

FREQUENTLY ASKED QUESTIONS FOR DIGITAL DOSE INHALERS MARKET:

1. What are digital dose inhalers?

The digital dose inhalers are devices that deliver a specific amount of medication to the lungs in the form of aerosolized medicine or dry powder. These inhalers have built-in sensors that detect use of inhaler and measure respiratory flow, according to the release and dose management.

2. What is the global market for digital dose inhalers?

The global digital dose inhalers market will grow at a CAGR of 11.27% during the forecast period from 2024 to 2030.

3. What are the drivers for global digital dose inhalers market?

The digital dose inhalers market is witnessing a positive market growth owing to the factors such as increasing of prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others. Further, the surge in the adoption of digital technology by key pharmaceutical players, rising air pollution, and increase in the population of smokers will aid in driving the market of digital dose inhalers. Also, the increasing product launches and regulatory approvals will create an exigency for the digital dose inhalers market.

4. Who are the key players operating in the global digital dose inhalers market?

Some of the key market players operating in the digital dose inhalers market includes Glenmark Pharmaceuticals, Novartis AG, ResMed, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., H&T Presspart Manufacturing Ltd., AptarGroup, Inc., Amiko Digital Health Limited., Trudell Medical UK Limited, BreatheSuite Inc., Opko Health, Inc., Cipla Inc., Sensirion AG, 3M, adherium, and others.

5. Which region has the highest share in digital dose inhalers market?

Among all the regions, North America is estimated to amass the significant revenue share in the global digital dose inhalers market. This can be ascribed to the escalating prevalence of various respiratory disorders, increasing burden of geriatric population prone to respiratory disorder, and the presence of key market players in the region are another factors which acts as a supportive factor for the North America's digital dose inhalers market growth.

Table of Contents

1. Digital Dose Inhalers Market Report Introduction

2. Digital Dose Inhalers Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Digital Dose Inhalers Market Key Factors Analysis

  • 4.1 Digital Dose Inhalers Market Drivers
    • 4.1.1 Rising prevalence of chronic respiratory diseases
    • 4.1.2 Surging geriatric population afflicted with respiratory disorders
    • 4.1.3 Growing demand for technology-enabled features of respiratory devices
  • 4.2 Digital Dose Inhalers Market Restraints and Challenges
    • 4.2.1 High Cost of the Devices
    • 4.2.2 Concerns regarding the accuracy of digital data
  • 4.3 Digital Dose Inhalers Market Opportunities
    • 4.3.1 Improving healthcare infrastructure in under-developed and developing countries

5. Digital Dose Inhalers Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Digital Dose Inhalers Market

7. Digital Dose Inhalers Market Layout

  • 7.1 By Product Type
    • 7.1.1 Dry Powder Inhalers
    • 7.1.2 Metered Dose Inhalers
  • 7.2 By Application
    • 7.2.1 Chronic Obstructive Pulmonary Disease
    • 7.2.2 Asthma
    • 7.2.3 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.1.2 Canada Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.1.3 Mexico Digital Dose Inhalers Market in USD million (2021-2030)
    • 7.3.2 Europe
      • 7.3.2.1 France Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.2.2 Germany Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.2.3 United Kingdom Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.2.4 Italy Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.2.5 Spain Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.2.6 Rest of Europe Digital Dose Inhalers Market in USD million (2021-2030)
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.3.2 Japan Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.3.3 India Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.3.4 Australia Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.3.5 South Korea Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.3.6 Rest of Asia Pacific Digital Dose Inhalers Market in USD million (2021-2030)
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1. Middle East Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.4.2 Africa Digital Dose Inhalers Market in USD million (2021-2030)
      • 7.3.4.3 South America Digital Dose Inhalers Market in USD million (2021-2030)

8. Digital Dose Inhalers Market Global Company Share Analysis - Key 3-5 Companies

9. Digital Dose Inhalers Market Company and Product Profiles

  • 9.1 Glenmark Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Novartis AG
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 ResMed
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Koninklijke Philips N.V.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Teva Pharmaceutical Industries Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 H&T Presspart Manufacturing Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 AptarGroup, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Amiko Digital Health Limited.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Trudell Medical UK Limited
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 BreatheSuite Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Opko Health, Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Cipla Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Sensirion AG
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 3M
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 adherium
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Digital Dose Inhalers Market
  • Table 3 Digital Dose Inhalers Market Analysis in Global (2021-2030)
  • Table 4 Digital Dose Inhalers Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Digital Dose Inhalers Market Analysis in Global by Application (2021-2030)
  • Table 6 Digital Dose Inhalers Market Analysis in Global by Geography (2021-2030)
  • Table 7 Digital Dose Inhalers Market Analysis in North America (2021-2030)
  • Table 8 Digital Dose Inhalers Market Analysis in North America by Country (2021-2030)
  • Table 9 Digital Dose Inhalers Market Analysis in the US (2021-2030)
  • Table 10 Digital Dose Inhalers Market Analysis in Canada (2021-2030)
  • Table 11 Digital Dose Inhalers Market Analysis in Mexico (2021-2030)
  • Table 12 Digital Dose Inhalers Market Analysis in Europe (2021-2030)
  • Table 13 Digital Dose Inhalers Market Analysis in Europe by Country (2021-2030)
  • Table 14 Digital Dose Inhalers Market Analysis in France (2021-2030)
  • Table 15 Digital Dose Inhalers Market Analysis in Germany (2021-2030)
  • Table 16 Digital Dose Inhalers Market Analysis in the UK (2021-2030)
  • Table 17 Digital Dose Inhalers Market Analysis in Italy (2021-2030)
  • Table 18 Digital Dose Inhalers Market Analysis in Spain (2021-2030)
  • Table 19 Digital Dose Inhalers Market Analysis in Rest of Europe (2021-2030)
  • Table 20 Digital Dose Inhalers Market Analysis in Asia-Pacific (2021-2030)
  • Table 21 Digital Dose Inhalers Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 22 Digital Dose Inhalers Market Analysis in China (2021-2030)
  • Table 23 Digital Dose Inhalers Market Analysis in Japan (2021-2030)
  • Table 24 Digital Dose Inhalers Market Analysis in India (2021-2030)
  • Table 25 Digital Dose Inhalers Market Analysis in Australia (2021-2030)
  • Table 26 Digital Dose Inhalers Market Analysis in South Korea (2021-2030)
  • Table 27 Digital Dose Inhalers Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 28 Digital Dose Inhalers Market Analysis in Rest of World (2021-2030)
  • Table 29 Digital Dose Inhalers Market Analysis in Rest of World by Region (2021-2030)
  • Table 30 Digital Dose Inhalers Market Analysis in the Middle East (2021-2030)
  • Table 31 Digital Dose Inhalers Market Analysis in Africa (2021-2030)
  • Table 32 Digital Dose Inhalers Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Digital Dose Inhalers Market
  • Figure 3 Digital Dose Inhalers Market Analysis in Global (2021-2030)
  • Figure 4 Digital Dose Inhalers Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Digital Dose Inhalers Market Analysis in Global by Application (2021-2030)
  • Figure 6 Digital Dose Inhalers Market Analysis in Global by Geography (2021-2030)
  • Figure 7 Digital Dose Inhalers Market Analysis in North America (2021-2030)
  • Figure 8 Digital Dose Inhalers Market Analysis in North America by Country (2021-2030)
  • Figure 9 Digital Dose Inhalers Market Analysis in the US (2021-2030)
  • Figure 10 Digital Dose Inhalers Market Analysis in Canada (2021-2030)
  • Figure 11 Digital Dose Inhalers Market Analysis in Mexico (2021-2030)
  • Figure 12 Digital Dose Inhalers Market Analysis in Europe (2021-2030)
  • Figure 13 Digital Dose Inhalers Market Analysis in Europe by Country (2021-2030)
  • Figure 14 Digital Dose Inhalers Market Analysis in France (2021-2030)
  • Figure 15 Digital Dose Inhalers Market Analysis in Germany (2021-2030)
  • Figure 16 Digital Dose Inhalers Market Analysis in the UK (2021-2030)
  • Figure 17 Digital Dose Inhalers Market Analysis in Italy (2021-2030)
  • Figure 18 Digital Dose Inhalers Market Analysis in Spain (2021-2030)
  • Figure 19 Digital Dose Inhalers Market Analysis in Rest of Europe (2021-2030)
  • Figure 20 Digital Dose Inhalers Market Analysis in Asia-Pacific (2021-2030)
  • Figure 21 Digital Dose Inhalers Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 22 Digital Dose Inhalers Market Analysis in China (2021-2030)
  • Figure 23 Digital Dose Inhalers Market Analysis in Japan (2021-2030)
  • Figure 24 Digital Dose Inhalers Market Analysis in India (2021-2030)
  • Figure 25 Digital Dose Inhalers Market Analysis in Australia (2021-2030)
  • Figure 26 Digital Dose Inhalers Market Analysis in South Korea (2021-2030)
  • Figure 27 Digital Dose Inhalers Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 28 Digital Dose Inhalers Market Analysis in Rest of World (2021-2030)
  • Figure 29 Digital Dose Inhalers Market Analysis in Rest of World by Region (2021-2030)
  • Figure 30 Digital Dose Inhalers Market Analysis in the Middle East (2021-2030)
  • Figure 31 Digital Dose Inhalers Market Analysis in Africa (2021-2030)
  • Figure 32 Digital Dose Inhalers Market Analysis in South America (2021-2030)
  • Figure 33 Market Drivers
  • Figure 34 Market Barriers
  • Figure 35 Market Opportunities
  • Figure 36 PORTER's Five Force Analysis